MediPharm Labs Corp. (OTCMKTS:MEDIF – Get Free Report) saw a large decline in short interest in July. As of July 31st, there was short interest totaling 997 shares, a decline of 92.7% from the July 15th total of 13,638 shares. Based on an average daily volume of 168,076 shares, the short-interest ratio is presently 0.0 days.
MediPharm Labs Stock Down 2.0%
Shares of MEDIF traded down $0.00 during trading hours on Thursday, hitting $0.05. The stock had a trading volume of 112,072 shares, compared to its average volume of 82,009. The company’s fifty day moving average is $0.05 and its two-hundred day moving average is $0.05. MediPharm Labs has a 52 week low of $0.04 and a 52 week high of $0.08.
MediPharm Labs Company Profile
MediPharm Labs Corporation is a Canada-based company focused on the extraction, formulation and manufacturing of pharmaceutical-grade cannabis products. Through proprietary processes and a GMP-compliant facility in Mississauga, Ontario, the company produces high-purity distillates, isolates and advanced formulations tailored to both medical and adult-use markets.
The company’s core offerings include THC and CBD distillates, crystalline isolates, softgel capsules, oral thin films and sterile injectable products.
Featured Stories
- Five stocks we like better than MediPharm Labs
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for MediPharm Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MediPharm Labs and related companies with MarketBeat.com's FREE daily email newsletter.
